Effect Of Delta9-tetrahydrocannabinol, A Cannabinoid Receptor Agonist, On The Triggering Of Transient Lower Oesophageal Sphincter Relaxations In Dogs And Humans

Gastro-Esophageal Reflux Disease (GERD)

Key Findings

Trial on healthy human (placebo-controlled) volunteers and dogs

Information and Links


Link: Effect Of Delta9-tetrahydrocannabinol, A Cannabinoid Receptor Agonist, On The Triggering Of Transient Lower Oesophageal Sphincter Relaxations In Dogs And Humans

Year: 2009

DOI: 10.1111/j.1476-5381.2008.00010.x


Ratings

(How Ratings Work)

Gastro-Esophageal Reflux Disease (GERD) — 5


Demonstrable efficacy of cannabis for treatment of Gastro-Esophageal Reflux Disease (GERD) according to the results found in this study.

Drugs Used

THC (dogs), THC (humans); 10 mg and 20 mg